Bridgewater Advisors Inc. Purchases 900 Shares of Oracle Corporation $ORCL

Bridgewater Advisors Inc. boosted its position in Oracle Corporation (NYSE:ORCL) by 13.1% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 7,766 shares of the enterprise software provider’s stock after purchasing an additional 900 shares during the period. Bridgewater Advisors Inc.’s holdings in Oracle were worth $1,698,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in ORCL. Nuveen LLC bought a new stake in Oracle in the 1st quarter worth about $732,692,000. Vanguard Group Inc. grew its position in shares of Oracle by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock valued at $22,498,982,000 after acquiring an additional 3,513,464 shares during the period. Kingstone Capital Partners Texas LLC bought a new position in shares of Oracle during the 2nd quarter valued at approximately $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of Oracle by 79.2% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock valued at $648,572,000 after acquiring an additional 2,049,687 shares during the period. Finally, Assenagon Asset Management S.A. grew its position in shares of Oracle by 840.7% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock valued at $463,380,000 after acquiring an additional 1,894,157 shares during the period. 42.44% of the stock is owned by institutional investors.

Oracle Trading Up 2.2%

NYSE:ORCL opened at $262.60 on Monday. Oracle Corporation has a 12 month low of $118.86 and a 12 month high of $345.72. The stock has a market cap of $748.62 billion, a price-to-earnings ratio of 60.79, a P/E/G ratio of 2.96 and a beta of 1.53. The company has a 50-day moving average price of $277.97 and a 200-day moving average price of $227.06. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33.

Oracle (NYSE:ORCL) last issued its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.48 by ($0.01). The firm had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.The firm’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period last year, the firm posted $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities analysts predict that Oracle Corporation will post 5 EPS for the current year.

Oracle Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Thursday, October 9th. Oracle’s payout ratio is presently 46.30%.

Insider Activity at Oracle

In related news, CEO Clayton M. Magouyrk sold 40,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $276.64, for a total transaction of $11,065,600.00. Following the completion of the sale, the chief executive officer directly owned 154,030 shares in the company, valued at approximately $42,610,859.20. The trade was a 20.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Naomi O. Seligman sold 2,222 shares of the business’s stock in a transaction that occurred on Friday, September 26th. The shares were sold at an average price of $288.91, for a total transaction of $641,958.02. Following the sale, the director owned 29,225 shares of the company’s stock, valued at $8,443,394.75. This trade represents a 7.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 220,134 shares of company stock valued at $64,268,949 in the last three months. Corporate insiders own 40.90% of the company’s stock.

Analyst Ratings Changes

ORCL has been the subject of a number of research reports. Baird R W raised shares of Oracle to a “strong-buy” rating in a research report on Wednesday, October 8th. Melius Research increased their target price on shares of Oracle from $270.00 to $370.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. Weiss Ratings downgraded shares of Oracle from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Saturday, October 25th. Robert W. Baird started coverage on shares of Oracle in a research report on Wednesday, October 8th. They set an “outperform” rating and a $365.00 target price for the company. Finally, The Goldman Sachs Group restated a “neutral” rating and set a $320.00 price target on shares of Oracle in a research note on Monday, October 20th. Three research analysts have rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $323.69.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.